Kristen Gajewski - 01 Feb 2023 Form 3 Insider Report for AVIENT CORP (AVNT)

Role
SVP & CHRO
Signature
/s/ Lisa K. Kunkle, Power of Attorney For: Kristen Gajewski
Issuer symbol
AVNT
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
3
Filing time
08 Feb 2023, 09:45:18 UTC
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVNT Common Stock 929 01 Feb 2023 Direct
holding AVNT Common Stock 840 01 Feb 2023 Savings Plan Trust F1
holding AVNT Common Stock 95 01 Feb 2023 Supplemental Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVNT Restricted Stock Units 01 Feb 2023 Common Stock 769 Direct F2, F3
holding AVNT Restricted Stock Units 01 Feb 2023 Common Stock 670 Direct F3, F4
holding AVNT Restricted Stock Units 01 Feb 2023 Common Stock 668 Direct F3, F5
holding AVNT Stock Appreciation Rights 01 Feb 2023 Common Stock 1,150 $41.89 Direct F6
holding AVNT Stock Appreciation Rights 01 Feb 2023 Common Stock 700 $31.54 Direct F7
holding AVNT Stock Appreciation Rights 01 Feb 2023 Common Stock 1,466 $31.48 Direct F8
holding AVNT Stock Appreciation Rights 01 Feb 2023 Common Stock 2,570 $42.27 Direct F9
holding AVNT Stock Appreciation Rights 01 Feb 2023 Common Stock 2,300 $52.64 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The information in this report is based on a plan statement as of February 1, 2023.
F2 The restricted stock units vest 3 years from the date of grant on February 10, 2023.
F3 The restricted stock units include all dividend equivalents acquired since the date of grant. Dividend equivalents are subject to the same restrictions as the underlying grant of restricted stock units.
F4 The restricted stock units vest 3 years from the date of grant on February 8, 2024.
F5 The restricted stock units vest 3 years from the date of grant on February 14, 2025.
F6 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.
F7 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.
F8 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.
F9 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years.
F10 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.